Cyclooxygenase-Two (COX-2) Modulates Proliferation in Aggressive Fibromatosis (Desmoid Tumor)

Oncogene - United Kingdom
doi 10.1038/sj.onc.1204107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Aggressive Desmoid Fibromatosis of the Neck After Total Thyroidectomy

Ear, Nose and Throat Journal
MedicineOtorhinolaryngology
2018English

COX-2 Modulates Mammary Tumor Progression in Response to Collagen Density

Breast Cancer Research
Cancer ResearchOncology
2016English

Clinical Outcomes of Systemic Therapy for Patients With Deep Fibromatosis (Desmoid Tumor)

Cancer
Cancer ResearchOncology
2010English

Image Gallery: Complete Remission of Aggressive Desmoid-Type Fibromatosis After Low-Dose Methotrexate for 2 Weeks in a Child With Psoriasis

British Journal of Dermatology
DermatologyMedicine
2016English

Staghorn Sign: Extra-Abdominal Desmoid Fibromatosis

Journal of Medical Imaging and Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2018English

Aggressive Juvenile Mandibular Fibromatosis

Folia Medica
Medicine
2013English

Desmoid‐type Fibromatosis Arising From Thoracotomy Incision

Clinical Case Reports
Medicine
2019English

Aggressive Fibromatosis Treatment - Imatinib Challenges

Macedonian Journal of Medical Sciences
2012English

Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy